Ryan Specialty Group Holdings Inc (RYAN)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Ryan Specialty Group Holdings Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 15 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Analysts & Price Target
The price target sits 2.1% below the current price.
- Consensus
- Strong Buy
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.05 | -75.00 | 664 | 24.50 | 2.10 | 260 | 242 |
| 2025: Q1 | -0.22 | -458.00 | 690 | 25.00 | -4.00 | -143 | -160 |
| 2025: Q2 | 0.19 | 9.90 | 855 | 23.00 | 6.10 | 354 | 334 |
| 2025: Q3 | 0.11 | 76.20 | 755 | 24.80 | 4.10 | 170 | 156 |
| 2025: Q4 | 0.03 | -39.30 | 751 | 13.20 | 1.10 | 263 | 246 |
| 2026: Q1 | 0.31 | – | 795 | 15.20 | 5.10 | -167 | -181 |
| 2026: Q2 | – | – | 917 | 7.20 | 4.60 | 293 | 293 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Ryan Specialty Holdings, Inc. ist als Dienstleister für Spezialprodukte und -lösungen für Versicherungsmakler, -agenten und -versicherer in den USA, Kanada, dem Vereinigten Königreich, dem übrigen Europa, Indien, Singapur und international tätig.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 6,144 |
| Headquarters | Chicago, IL |
| Website | ryanspecialty.com |
| IPO Date | 22. Jul 2021 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Patrick G. Ryan | Founder & Executive Chairman | 1938 |
| Timothy William Turner | CEO & Director | 1961 |
| Stephen P. Keogh | Co-President & COO | 1968 |
| Janice M. Hamilton | Executive VP & CFO | 1983 |
| Benjamin Miles Wuller | Chief Executive officer of RSG Underwriting Managers | 1977 |
| Amber Carver | President | – |
| Brendan Martin Mulshine | Co-President & Chief Revenue Officer | 1966 |
| Bradley Eames Bodell B.S. | Chief Information Officer | 1966 |
| Nicholas J. Mezick C.F.A. | Vice President of Investor Relations | – |
| Michael Blackshear J.D. | Senior VP, Chief Compliance & Privacy Officer and Head of Diversity, Equity & Inclusion | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.